Brief: Cleveland Biolabs Inc Says Yakov Kogan Tendered His Resignation As CEO Of Co, Effective Dec.13
Nov 15 (Reuters) - Cleveland Biolabs Inc CBLI.O :
* CLEVELAND BIOLABS INC - YAKOV KOGAN TENDERED HIS
RESIGNATION AS
CEO OF CO, EFFECTIVE DEC.13
* CLEVELAND BIOLABS INC - BOARD OF DIRECTORS INTENDS TO
COMMENCE A
SEARCH FOR A REPLACEMENT CHIEF EXECUTIVE OFFICER
Source text: (https://bit.ly/33R6g31)
Further company coverage: CBLI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Statera Biopharma
See all news20/20 Biolabs jumps on Ebola, hantavirus testing plans
Tivic Health Systems rises after deal for late-stage immunotherapy drug
Brief: Tivic Health Acquires Exclusive Worldwide Rights To Phase III TLR5 Agonist
Brief: Statera Biopharma Inc Quarterly Loss Per Share $0.20
Brief: Statera Biopharma Inc - On October 12, 2022, Co Entered A Binding Memorandum Of Understanding (“MoU”) With Holobeam Technologies, Inc